Preview

Rational Pharmacotherapy in Cardiology

Advanced search

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT

https://doi.org/10.20996/1819-6446-2011-7-2-241-245

Full Text:

Abstract

The problem of generic drugs use in clinical practice and confirmation of their therapeutic equivalence is discussed. The significance of studies on generic drugs bioequivalence, as well as details of international practice and regulations in this area is explained.

About the Authors

N. P. Kutishenko

Russian Federation


S. Yu. Martsevich
State Research Center for Preventive Medicine I.M. Setchenov First Moscow State Medical University
Russian Federation


I. V. Vashurina
State Research Center for Preventive Medicine
Russian Federation


References

1. Martsevich S.Yu. Copies of the drugs, as well as copies of the art, are different. AIF-Zdorov'e 2010; 26:

2. Russian (Марцевич С.Ю. Копии лекарств, как и копии в искусстве, бывают разными. АИФ-Здоровье 2010; 26: 3).

3. Martsevich S.Yu. Pills for a replacement. What makes cheaper drugs from expensive. AIF-Zdorov'e 2011, 8: 35. Russian (Марцевич С.Ю. Таблетки на замену. Чем отличаются дешевые лекарства от дорогих. АИФ-Здоровье 2011; 8: 35).

4. Karpov Yu.A., Nedogoda S.V., Kislyak O.A. et al. The ORIGINAL program – main result. Kardiologia 2011; 3: 36-41. Russian (Карпов Ю.А., Недогода С.В., Кисляк О.А., и др. Основные результаты программы ОРИГИНАЛ. Кардиология 2011; 3: 36-41).

5. Johnston A., Staylas P., Stergiou G. Effectiveness, safety and cost of drug substitution in hypertension. Br J Clin Pharmacol 70: 3; 320-334.

6. Guidance for Industry Bioequivalence Recommendations for Specific Products. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). June 2010. Available on: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory-Information/Guidances/ucm072872.pdf

7. Proposal to waive in vivo bioequivalence requirements for the who model list of essential medicines immediate release, solid oral dosage forms. Working document QAS/04.109/Rev. Geneva: WHO; 2005. Available on: http://www.who.int/medicines/services/expertcommittees/pharmprep/ QAS04_109Rev1_Waive_invivo_bioequiv.pdf

8. Guideline on the investigation of bioequivalence. Doc. Ref. CPMP/EWP/QWP/1401/98 Rev. 1 Lon-don: EMEA; 2008. on: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003011.pdf

9. Federal Law of 12 April 2010 N 61-FZ "On the circulation of drugs. " Available on: http://www.consultant.ru/online/base/?req=doc;base=LAW;n=105700. Russian (Федеральный закон Российской Федерации от 12 апреля 2010 г. N 61-ФЗ "Об обращении лекарственных средств". Доступно на: http://www.consultant.ru/online/base/?req=doc;base=LAW;n=105700).

10. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues. London: EMEA; 2006. Available on: http://www.ema. europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003953.pdf

11. World Medical Association Statement on Generic Drug Substitution Adopted by the 41st World Medical Assembly Hong Kong, September 1989 and rescinded at the WMA General Assembly, Santiago 2005. Available on: http://www.wma.net/en/30publications/10policies/20archives/d9/index.html

12. National guidelines for a rational pharmacotherapy of patients with cardiovascular diseases. Available on: http://www.scardio.ru/downloads/c4m0i257/recomendacii.doc. Russian Национальные рекомендации по рациональной фармакотерапии больных сердечно-сосудистыми заболеваниями. Доступно на: http://www.scardio.ru/downloads/c4m0i257/recomendacii.doc

13. Iakusevich V.V. Qualitative drug: what should it look like? Rational Pharmacother Cardiol 2006; 4: 41-46. Russian (Якусевич В.В. Качественное лекарственное средство: каким оно должно быть. Рациональная Фармакотерапия в Кардиологии 2006; 4: 41-46).

14. Revel'skiy I.A. Way of comparative physiological assessment of pharmaceutical substances and preparations on their basis. Vestnik Roszdravnadzora 2009; 4: 48-51. Russian (Ревельский И.А. Способ сравнительной физиологической оценки фармацевтических субстанций и препаратов на их основе. Вестник Росздравнадзора 2009; 4: 48-51).

15. Martsevich S.Yu., Kutishenko N.P., Deev A.D. Original and generic drugs in cardiology. Can you solve the problem of interchangeability. Vestnik Roszdravnadzora 2009; 4: 48-51. Russian (Марцевич С.Ю., Кутишенко Н.П., Деев А.Д. Оригинальные препараты и дженерики в кардиологии. Можно ли решить проблему взаимозаменяемости. Вестник Росздравнадзора 2009; 4: 48-51).

16. Registry of clinical controlled randomized studies performed with generics in Russia. Available on: http://cardiodrug.ru/?page_id=572. Russian (Реестр клинических контролируемых рандомизированных исследований, выполненных с дженериками в России. Доступно на: http://car-diodrug.ru/?page_id=572)

17. National guidelines for diagnosis and treatment of stable angina. Kardiovaskulyarnaya terapiya i profilaktika 2008; 7(6) suppl 4: 1-45. Russian (Национальные рекомендации по диагностике и лечению стабильной стенокардии. Кардиоваскулярная терапия и профилактика 2008; 7(6) Приложение 4: 1-45).


For citation:


Kutishenko N.P., Martsevich S.Yu., Vashurina I.V. WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT. Rational Pharmacotherapy in Cardiology. 2011;7(2):241-245. (In Russ.) https://doi.org/10.20996/1819-6446-2011-7-2-241-245

Views: 491


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)